AMBS

Amarantus Bioscience Holdings, Inc.

 
Common Stock Alternative Reporting
Pink Current Information
Verified Company Profile 12/07/2017
Contact Info
  • 953 Indiana St.
  • San Francisco, CA 94107

Business Description


 
Financial Reporting/Disclosure
Reporting Status Alternative Reporting Standard
Deregistered a/o Dec 04, 2017
Audited Financials Audited
Latest Report Sep 30, 2017 Quarterly Report
CIK 0001424812
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2008
Employees 5 a/o Dec 06, 2017
Company Officers/Contacts
Gerald E. Commissiong CEO, President, COO
John W. Commissiong CSO
Company Directors
Gerald E. Commissiong
John W. Commissiong
Robert L. Harris
Donald D. Huffman
Steve Spence
Steven Spence
Company Notes
  • Formerly=Amarantus Bioscience, Inc. until 4-2013
  • Formerly=Amarantus Biosciences, Inc. until 12-2012
  • Formerly=Jumpkicks, Inc. until 6-2011
Service Providers
Accounting/Auditing Firm
Marcum LLP
750 Third Ave
11th Floor
New York, NY, 10017
United States

Legal Counsel
Sheppard, Mullin, Richter & Hampton LLP
30 Rockefeller Plaza
New York, NY, 10112-0015
United States

Investor Relations Firm
Not Available
AMBS Security Details
Share Structure
Market Value1 $13,614,644 a/o Dec 15, 2017
Authorized Shares 150,000,000 a/o Dec 01, 2017
Outstanding Shares 119,426,698 a/o Dec 01, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 75,956,228 a/o Dec 06, 2017
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders
Shareholders of Record 68 a/o Jun 01, 2016
Short Selling Data
Short Interest 26,681 (26,581%)
Nov 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security